OtherErratum
CORRECTION TO “CHARACTERIZATION OF DASATINIB AND ITS STRUCTURAL ANALOGS AS CYP3A4 MECHANISM-BASED INACTIVATORS AND THE PROPOSED BIOACTIVATION PATHWAYS”
Drug Metabolism and Disposition October 2009, 37 (10) 2118; DOI: https://doi.org/10.1124/dmd.37.10.2118